share_log

Ginkgo Bioworks | DEF 14A: Definitive information statements

Ginkgo Bioworks | DEF 14A: Definitive information statements

Ginkgo Bioworks | DEF 14A：股東委託書決議
美股sec公告 ·  04/30 04:06
牛牛AI助理已提取核心訊息
Ginkgo Bioworks Holdings, Inc. (Ginkgo) has announced its 2024 Annual Meeting of Shareholders to be held virtually on June 13, 2024. The meeting will allow shareholders to participate online and vote electronically. The proxy statement accompanying the notice outlines the business to be considered at the meeting, which includes the election of nine director nominees, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of executive compensation. Shareholders as of the record date, April 16, 2024, are entitled to vote. The proxy materials and Ginkgo's 2023 Annual Report are available at www.proxyvote.com. The Board of Directors recommends voting for each director nominee and for the ratification of the appointment of Deloitte & Touche LLP. The meeting will also address the election of Class B Directors, the approval of executive compensation, and other business as may arise.
Ginkgo Bioworks Holdings, Inc. (Ginkgo) has announced its 2024 Annual Meeting of Shareholders to be held virtually on June 13, 2024. The meeting will allow shareholders to participate online and vote electronically. The proxy statement accompanying the notice outlines the business to be considered at the meeting, which includes the election of nine director nominees, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of executive compensation. Shareholders as of the record date, April 16, 2024, are entitled to vote. The proxy materials and Ginkgo's 2023 Annual Report are available at www.proxyvote.com. The Board of Directors recommends voting for each director nominee and for the ratification of the appointment of Deloitte & Touche LLP. The meeting will also address the election of Class B Directors, the approval of executive compensation, and other business as may arise.
Ginkgo Bioworks Holdings, Inc.（Ginkgo）宣佈其2024年年度股東大會將於2024年6月13日虛擬舉行。該會議將允許股東在線參與和電子投票。通知所附的委託書概述了會議將要考慮的業務，其中包括選舉九名董事候選人，批准德勤會計師事務所爲截至2024年12月31日的財政年度的獨立註冊會計師事務所，以及批准高管薪酬。截至記錄日期，即2024年4月16日，股東有權投票。代理材料和銀杏的2023年年度報告可在www.proxyvote.com上查閱。董事會建議對每位董事候選人進行投票，並批准德勤會計師事務所的任命。會議還將討論B類董事的選舉、高管薪酬的批准以及可能出現的其他事項。
Ginkgo Bioworks Holdings, Inc.（Ginkgo）宣佈其2024年年度股東大會將於2024年6月13日虛擬舉行。該會議將允許股東在線參與和電子投票。通知所附的委託書概述了會議將要考慮的業務，其中包括選舉九名董事候選人，批准德勤會計師事務所爲截至2024年12月31日的財政年度的獨立註冊會計師事務所，以及批准高管薪酬。截至記錄日期，即2024年4月16日，股東有權投票。代理材料和銀杏的2023年年度報告可在www.proxyvote.com上查閱。董事會建議對每位董事候選人進行投票，並批准德勤會計師事務所的任命。會議還將討論B類董事的選舉、高管薪酬的批准以及可能出現的其他事項。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。